Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library

Abstract The rise of drug-resistant fungal pathogens, including Candida auris, highlights the urgent need for innovative antifungal therapies. We have developed a cost-effective platform combining microbial extract prefractionation with rapid mass spectrometry-bioinformatics-based dereplication to e...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuefei Chen, Kalinka Koteva, Sommer Chou, Allison Guitor, Daniel Pallant, Yunjin Lee, David Sychantha, Shawn French, Dirk Hackenberger, Nicole Robbins, Michael A. Cook, Eric D. Brown, Lesley T. MacNeil, Leah E. Cowen, Gerard D. Wright
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-62630-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332294375964672
author Xuefei Chen
Kalinka Koteva
Sommer Chou
Allison Guitor
Daniel Pallant
Yunjin Lee
David Sychantha
Shawn French
Dirk Hackenberger
Nicole Robbins
Michael A. Cook
Eric D. Brown
Lesley T. MacNeil
Leah E. Cowen
Gerard D. Wright
author_facet Xuefei Chen
Kalinka Koteva
Sommer Chou
Allison Guitor
Daniel Pallant
Yunjin Lee
David Sychantha
Shawn French
Dirk Hackenberger
Nicole Robbins
Michael A. Cook
Eric D. Brown
Lesley T. MacNeil
Leah E. Cowen
Gerard D. Wright
author_sort Xuefei Chen
collection DOAJ
description Abstract The rise of drug-resistant fungal pathogens, including Candida auris, highlights the urgent need for innovative antifungal therapies. We have developed a cost-effective platform combining microbial extract prefractionation with rapid mass spectrometry-bioinformatics-based dereplication to efficiently prioritize previously uncharacterized antifungal scaffolds. Screening C. auris and Candida albicans reveals coniotins, lipopeptaibiotics isolated from Coniochaeta hoffmannii, which are undetectable in crude extracts. Coniotins exhibits potent activity against critical priority fungal pathogens listed by the World Health Organization, including C. albicans, Cryptococcus neoformans, multidrug-resistant Candida auris, and Aspergillus fumigatus, with high selectivity and low resistance potential. Coniotin A targets beta-glucan, compromising fungal cell wall integrity, remodelling, and sensitizing C. auris to caspofungin. Identification of its hybrid polyketide synthase–nonribosomal peptide synthetase biosynthetic gene cluster facilitates discovering structurally diverse lipopeptaibiotics. Here, we show that natural product prefractionation enables the discovery of previously hidden bioactive scaffolds and introduces coniotins as candidates for combating multidrug-resistant fungal pathogens.
format Article
id doaj-art-3f77fdd6355440518ebc1d6ef44d5849
institution Kabale University
issn 2041-1723
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-3f77fdd6355440518ebc1d6ef44d58492025-08-20T03:46:15ZengNature PortfolioNature Communications2041-17232025-08-0116111910.1038/s41467-025-62630-zConiontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation libraryXuefei Chen0Kalinka Koteva1Sommer Chou2Allison Guitor3Daniel Pallant4Yunjin Lee5David Sychantha6Shawn French7Dirk Hackenberger8Nicole Robbins9Michael A. Cook10Eric D. Brown11Lesley T. MacNeil12Leah E. Cowen13Gerard D. Wright14David Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDepartment of Molecular Genetics, University of TorontoDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDepartment of Molecular Genetics, University of TorontoDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityDepartment of Molecular Genetics, University of TorontoDavid Braley Centre for Antibiotic Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster UniversityAbstract The rise of drug-resistant fungal pathogens, including Candida auris, highlights the urgent need for innovative antifungal therapies. We have developed a cost-effective platform combining microbial extract prefractionation with rapid mass spectrometry-bioinformatics-based dereplication to efficiently prioritize previously uncharacterized antifungal scaffolds. Screening C. auris and Candida albicans reveals coniotins, lipopeptaibiotics isolated from Coniochaeta hoffmannii, which are undetectable in crude extracts. Coniotins exhibits potent activity against critical priority fungal pathogens listed by the World Health Organization, including C. albicans, Cryptococcus neoformans, multidrug-resistant Candida auris, and Aspergillus fumigatus, with high selectivity and low resistance potential. Coniotin A targets beta-glucan, compromising fungal cell wall integrity, remodelling, and sensitizing C. auris to caspofungin. Identification of its hybrid polyketide synthase–nonribosomal peptide synthetase biosynthetic gene cluster facilitates discovering structurally diverse lipopeptaibiotics. Here, we show that natural product prefractionation enables the discovery of previously hidden bioactive scaffolds and introduces coniotins as candidates for combating multidrug-resistant fungal pathogens.https://doi.org/10.1038/s41467-025-62630-z
spellingShingle Xuefei Chen
Kalinka Koteva
Sommer Chou
Allison Guitor
Daniel Pallant
Yunjin Lee
David Sychantha
Shawn French
Dirk Hackenberger
Nicole Robbins
Michael A. Cook
Eric D. Brown
Lesley T. MacNeil
Leah E. Cowen
Gerard D. Wright
Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
Nature Communications
title Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
title_full Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
title_fullStr Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
title_full_unstemmed Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
title_short Coniontins, lipopetaibiotics active against Candida auris identified from a microbial natural product fractionation library
title_sort coniontins lipopetaibiotics active against candida auris identified from a microbial natural product fractionation library
url https://doi.org/10.1038/s41467-025-62630-z
work_keys_str_mv AT xuefeichen coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT kalinkakoteva coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT sommerchou coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT allisonguitor coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT danielpallant coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT yunjinlee coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT davidsychantha coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT shawnfrench coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT dirkhackenberger coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT nicolerobbins coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT michaelacook coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT ericdbrown coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT lesleytmacneil coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT leahecowen coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary
AT gerarddwright coniontinslipopetaibioticsactiveagainstcandidaaurisidentifiedfromamicrobialnaturalproductfractionationlibrary